Risk of osteoporotic fracture lower with DOACs than warfarin

    This is a preview of subscription content, log in to check access.

    Reference

    1. Lau WCY, et al. Association Between Treatment With Apixaban, Dabigatran, Rivaroxaban, or Warfarin and Risk for Osteoporotic Fractures Among Patients With Atrial Fibrillation. A Population-Based Cohort Study. Annals of Internal Medicine : 19 May 2020. Available from: URL: https://doi.org/10.7326/M19-3671

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Risk of osteoporotic fracture lower with DOACs than warfarin. Reactions Weekly 1806, 14 (2020). https://doi.org/10.1007/s40278-020-79032-8

    Download citation